French independent pharma company Servier says it has appointed David Lee to its executive committee as executive vice ...
Medicines Discovery Catapult (MDC), the UK government-backed life sciences service dedicated to driving productivity and ...
US fibrosis-focused drug developer Mediar Therapeutics has entered into global licensing agreement with US pharma major Eli ...
California-based immunology start-up Ouro Medicines, which is developing immune reset therapeutics for people living with ...
Shares of USA-based Intra-Cellular Therapies leapt almost 36% to $128.85 in pre-marker activity today, as rumors of a ...
US radiopharmaceuticals-focused Lantheus Holdings today announced a definitive agreement to acquire Life Molecular Imaging.
UK pharma major GSK is to acquire IDRx, a Boston, USA-based, clinical-stage biopharma developing precision therapeutics for ...
CNX Therapeutics partners with Klaria Pharma to market sumatriptan alginate film in Europe, addressing critical migraine ...
Aragen Life Sciences secures $100M investment from Quadria Capital, valuing the CRDMO at $1.4B. The funding supports ...
AbbVie records a $3.5 billion impairment charge following the failure of emraclidine in Phase II schizophrenia trials.
New export figures for November from Statistics Denmark show that medicine constitutes a significant part of total Danish ...
Gilead Sciences and Danish dermatology specialist LEO Pharma announced a strategic partnership, marking another move outside ...